251 286 - Biotech Bayern

Inamed Research GmbH & Co. KG
CRO
Keywords: Drug Delivery, Clinical Research, Monitoring, Medical Writing,
Respiratory Diseases
Inhalation medicine is our expertise.Inamed Research was founded in 1998 as
a spin off from the GSF. You profit from more than 30 years of our experience
in aerosol bio-physics and aerosol technology and from our large network of
experts.Inamed’s competence is inhalation therapy with regard to clinical trials
from phase I to IV and inhalation device testing. One of our specialties is the use
of radioactive labeled drugs to determine lung deposition in scintigraphy trials,
investigating mucociliary clearance and the analysis of the breathing pattern.
In the division device testing, we characterize devices, not only with regard to
particle size, output and flow, but also in realistic simulations, to establish the
performance of the device when a patient is using it.
Infors GmbH
BIOTECH DEVICES & REAGENTS
Infors is specialised in marketing and maintenance of fermenters and shakers.
As a subsidiary of Infors AG in Basel, Switzerland, it not only sees itself as a
trading and service company but also cooperates with researchers in order to
develop new equipment used in the field of microbiology and cell culture.
Ingenium Pharmaceuticals AG
BIOTECH THERAPEUTICS & DIAGNOSTICS
Keywords: Autoimmune Diseases, Knock Out, Medicinal Chemistry,
Small Molecules, Inflammation, Rheumatology
Ingenium Pharmaceuticals is advancing its expertise in drug target discovery
and genetics-based therapeutic research toward the development of novel
treatments for pain and inflammatory disease. To date, Ingenium has used its
forward and reverse genetics technologies for its partners and for its internal
drug development programs across several therapeutic areas. Ingenium´s
largest partnership is a multi-year drug discovery and development collaboration
with Elan Parmaceuticals. In addition, Ingenium has signed numerous
agreements across the biopharmaceutical industry and academia to provide
genetic expertise and animal models. Privately-held, Ingenium has raised three
rounds of funding from premier US and European venture funds.
In 2007 Probiodrug AG acquired Ingenium.
Contact:
Dr. Thomas Meyer
Robert-Koch-Allee 29
D-82131 Gauting
Phone: +49 (0) 89 89 35 69 0
Fax: +49 (0) 89 89 35 69 22
E-Mail: info@inamed.eu
Internet: www.inamed.eu
Contact:
Werner Mayer
Tannenweg 2
D-85254 Einsbach
Phone: +49 (0) 8135 8333
Fax: +49 (0) 8135 8320
E-Mail: infors.de@infors-ht.com
Internet: www.infors-ht.com
Contact:
Susanne Imsel
Fraunhoferstr. 13
D-82152 Martinsried
Phone: +49 (0) 89 8565-2310
Fax: +49 (0) 89 8565-2305
E-Mail: info@ingenium-ag.com
Internet: www.ingenium-ag.com
75